BRAFV600E mutation is a negative prognosticator in pediatric ganglioglioma

Acta Neuropathologica

Volumn 125, Issue 6, 2013, Pages 901-910

  Dahiya, Sonika ^a   Haydon, Devon H ^a   Alvarado, David ^a   Gurnett, Christina A ^a   Gutmann, David H ^a   Leonard, Jeffrey R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BRAFV600E; Children; Ganglioglioma; Recurrence free survival

Indexed keywords

B RAF KINASE;

ADOLESCENT; ADULT; ARTICLE; CELL DENSITY; CELL INFILTRATION; CELL PROLIFERATION; CELL STRUCTURE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; GENE MUTATION; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE FREE SURVIVAL; RECURRENT DISEASE; SCHOOL CHILD; SURVIVAL RATE; SURVIVAL TIME;

ADOLESCENT; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; GANGLIOGLIOMA; HUMANS; INFANT; MALE; MUTANT PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; SURVIVAL RATE; YOUNG ADULT;

EID: 84878545588     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-013-1120-y     Document Type: Article

References (32)

1. Bar EE, Lin A, Tihan T, Burger PC, Eberhart CG (2008) Frequent gains at chromosome 7q34 involving BRAF in pilocytic astrocytoma. J Neuropathol Exp Neurol 67:878-887
2. Brat DJ, Parisi JE, Kleinschmidt-DeMasters BK, Yachnis A, Montine T, Boyer P, Powell S, Prayson R, McLendon R (2008) Surgical neuropathology update: a review of changes introduced by the WHO classification of tumours of the central nervous system, 4th edition. Arch Pathol Lab Med 132:993-1007
3. Burger PC, Scheithauer BW (2008) Tumors of the central nervous system. (AFIP Atlas of Tumor Pathology, Series IV, Fascicle 7)
4. Capper D, Preusser M, Habel A, Sahm F, Ackermann U, Schindler G, Pusch S, Mechtersheimer G, Zentgraf H, von Deimling A (2011) Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody. Acta Neuropathol 122:11-19
5. Chapman PB, Hauschild A, Robert C, Haanen J, Ascierto P, Larkin J, Dummer R, Garbe C, Testori A, Maio M, Hogg D, Lorigan P, Lebbe C, Jouary T, Schadendorf D, Ribas A, O'Day S, Sosman J, Kirkwood J, Eggermont A, Dreno B, Nolop K, Li J, Nelson B, Hou J, Lee R, Flaherty K, McArthur G (2011) Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 364:2507-2516
6. Chintagumpala MM, Armstrong D, Miki S, Nelson T, Cheek W, Laurent J, Woo S, Mahoney D Jr (1996) Mixed neuronal-glial tumors (gangliogliomas) in children. Pediatr Neurosurg 24:306-313
7. Donahue B, Scott CB, Nelson JS, Rotman M, Murray K, Nelson D, Banker F, Earle J, Fischbach J, Asbell S, Gaspar L, Markoe A, Curran W (1997) Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: a report of Radiation Therapy Oncology Group 83-02. Int J Radiat Oncol Biol Phys 38:911-914
8. Dougherty MJ, Santi M, Brose M, Ma C, Resnick A, Sievert A, Storm P, Biegel J (2010) Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas. Neuro Oncol 12:621-630
9. El Khashab M, Gargan L, Margraf L, Koral K, Nejat F, Swift D, Weprin B, Bowers D (2009) Predictors of tumor progression among children with gangliogliomas. Clinical article. J Neurosurg Pediatr 3:461-466
10. Haddad SF, Moore SA, Menezes AH, VanGilder JC (1992) Ganglioglioma: 13 years of experience. Neurosurgery 31:171-178
11. Horbinski C, Kofler J, Yeaney G, Camelo-Piragua S, Venneti S, Louis D, Perry A, Murdoch G, Nikiforova M (2011) Isocitrate dehydrogenase 1 analysis differentiates gangliogliomas from infiltrative gliomas. Brain Pathol 21:564-574
12. Johnson JH Jr, Hariharan S, Berman J, Sutton L, Rorke L, Molloy P, Phillips P (1997) Clinical outcome of pediatric gangliogliomas: ninety-nine cases over 20 years. Pediatr Neurosurg 27:203-207
13. Jones DT, Kocialkowski S, Liu L, Pearson D, Backlund L, Ichimura K, Collins V (2008) Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res 68:8673-8677
14. Jones DT, Mulholland SA, Pearson DM, Malley DS, Openshaw SWS, Lambert SR, Liu L, Backlund LM, Ichimura K, Collins VP (2011) Adult grade II diffuse astrocytomas are genetically distinct from and more aggressive than their paediatric counterparts. Acta Neuropathol 121:753-761
15. Khajavi K, Comair YG, Prayson RA, Wyllie E, Palmer J, Estes M, Hahn J (1995) Childhood ganglioglioma and medically intractable epilepsy. A clinicopathological study of 15 patients and a review of the literature. Pediatr Neurosurg 22:181-188
16. Koelsche C, WÖhrer A, Jeibman A, Schittenhelm J, Schindler G, Preusser M, Lastischka F, von Deimling A, Capper D (2013) Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cells. Acta Neuropathol Feb 24 [Epub ahead of print]. PMID: 23435618
17. Leighton C, Fisher B, Bauman G, Depiero S, Stitt L, MacDonald D, Cairncross G (1997) Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. J Clin Oncol 15:1294-1301
18. Long GV, Wilmott JS, Capper D, Preusser M, Zhang Y, Thompson J, Kefford R, von Deimling A, Scolyer R (2013) Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma. Am J Surg Pathol 37(1):61-65
19. Louis DN, Ohgaki H, Wiestler OD, Cavenee W, Burger P, Jouvet A, Scheithauer B, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97-109
20. Luyken C, Blumcke I, Fimmers R, Urbach H, Wiestler OD, Schramm J (2004) Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years. Cancer 101:146-155
21. Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8:1277-1280
22. Majores M, von Lehe M, Fassunke J, Schramm J, Becker AJ, Simon M (2008) Tumor recurrence and malignant progression of gangliogliomas. Cancer 113:3355-3363
23. Ogiwara H, Nordli DR, DiPatri AJ, Alden TD, Bowman RM, Tomita T (2010) Pediatric epileptogenic gangliogliomas: seizure outcome and surgical results. J Neurosurg Pediatr 5:271-276
24. Pfister S, Janzarik WG, Remke M, Ernst A, Werft W, Becker N, Toedt G, Wittmann A, Kratz C, Olbrich H, Ahmadi R, Thieme B, Joos S, Radlwimmer B, Kulozik A, Pietsch T, Herold-Mende C, Gnekow A, Reifenberger G, Korshunov A, Scheurlen W, Omran H, Lichter P (2008) BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. J Clin Invest 118:1739-1749
25. Pollack IF, Hamilton RL, Sobol RW, Nikiforova M, Lyons-Weiler M, LaFramboise W, Burger P, Brat D, Rosenblum M, Holmes E, Zhou T, Jakacki R (2011) IDH1 mutations are common in malignant gliomas arising in adolescents: a report from the Children's Oncology Group. Childs Nerv Syst 27:87-94
26. Pupa SM, Bufalino R, Invernizzi AM, Andreola S, Rilke F, Lombardi L, Colnaghi M, Menard S (1996) Macrophage infiltrate and prognosis in c-erbB-2-overexpressing breast carcinomas. J Clin Oncol 14:85-94
27. Russell DS, Rubinstein LJ (1962) Ganglioglioma: a case with long history and malignant evolution. J Neuropathol Exp Neurol 21:185-193
28. Schindler G, Capper D, Meyer J, Janzarik W, Omran H, Herold-Mende C, Schmieder K, Wesseling P, Mawrin C, Hasselblatt M, Louis D, Korshunov A, Pfister S, Hartmann C, Paulus W, Reifenberger G, von Deimling A (2011) Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol 121:397-405
29. Smith NM, Carli MM, Hanieh A, Clark B, Bourne AJ, Byard RW (1992) Gangliogliomas in childhood. Childs Nerv Syst 8:258-262
30. Sutton LN, Packer RJ, Rorke LB, Bruce DA, Schut L (1983) Cerebral gangliogliomas during childhood. Neurosurgery 13:124-128
31. Yang I, Tihan T, Han SJ, Wrensch M, Wiencke J, Sughrue M, Parsa A (2010) CD8+ T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survival. J Clin Neurosci 17:1381-1385
32. Yu J, Deshmukh H, Gutmann RJ, Emnett R, Rodriguez F, Watson M, Nagarajan R, Gutmann D (2009) Alterations of BRAF and HIPK2 loci predominate in sporadic pilocytic astrocytoma. Neurology 73:1526-1531